Apolipoprotein J (clusterin) activates rodent microglia in vivo and in vitro

Journal of Neurochemistry

Volumn 93, Issue 4, 2005, Pages 1038-1046

  Xie, Z ^a,e   Harris White, M E ^b,d   Wals, P A ^a   Frautschy, S A ^b,c,d   Finch, C E ^a   Morgan, Todd E ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Alzheimer's; apoJ; Clusterin; Microglia; Neurotoxicity; Nitric oxide; Tumor necrosis factor

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 NITRO 5 THIOCYANATOBENZOIC ACID; AMINOGUANIDINE; BENZOIC ACID DERIVATIVE; CLUSTERIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MONOCLONAL ANTIBODY; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHOTYROSINE; PROTEIN KINASE C INHIBITOR; REACTIVE NITROGEN SPECIES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CHRONIC INFLAMMATION; CONTROLLED STUDY; DOSE RESPONSE; IMMUNOHISTOCHEMISTRY; MICROGLIA; NEUROTOXICITY; NONHUMAN; PARENCHYMA; PHENOTYPE; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, NEWBORN; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; CLUSTERIN; COMPLEMENT HEMOLYTIC ACTIVITY ASSAY; COMPLEMENT INACTIVATOR PROTEINS; DIAGNOSTIC IMAGING; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLAVONOIDS; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERONS; MICROGLIA; MOLECULAR CHAPERONES; NEURONS; NITRITES; PHOSPHORYLATION; PHOSPHOTYROSINE; RATS; RATS, INBRED F344; THIOCYANATES; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

RODENTIA;

EID: 18844379354     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03065.x     Document Type: Article

References (63)

1. Bamberger M. E., Harris M. E., McDonald D. R., Husemann J. and Landreth G. E. (2003) A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. J. Neurosci. 23, 2665-2674.
2. Bertrand P., Poirier J., Oda T., Finch C. E. and Pasinetti G. M. (1995) Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease. Brain Res. Mol. Brain Res. 33, 174-178.
3. Blasi E., Barluzzi R., Bocchini V., Mazzolla R. and Bistoni F. (1990) Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J. Neuroimmunol. 27, 229-237.
4. Boggs L. N., Fuson K. S., Bae Z. M., Churgay L., McClure D., Becker G. and May P. C. (1996) Clusterin (Apo J) protects against in vitro amyloid-beta (1-40) neurotoxicity. J. Neurochem. 67, 1324-1327.
5. Calero M., Tokuda T., Rostagno A., Kumar A., Zlokovic B., Frangione B. and Ghiso J. (1999) Functional and structural properties of lipid-associated apolipoprotein J (clusterin). Biochem. J. 344 Part 2, 375-383.
6. Chao C. C., Hu S., Ehrlich L. and Peterson P. K. (1995) Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav. Immun. 9, 355-365.
7. Choi-Miura N. H., Ihara Y., Fukuchi K., Takeda M., Nakano Y., Tobe T. and Tomita M. (1992) SP-40,40 is a constituent of Alzheimer's amyloid. Acta Neuropathol. (Berl.) 83, 260-264.
8. Chun J. T., Wang L., Pasinetti G. M., Finch C. E. and Zlokovic B. V. (1999) Glycoprotein 330/megalin (LRP-2) has low prevalence as mRNA and protein in brain microvessels and choroid plexus. Exp. Neurol. 157, 194-201.
9. Combs C. K., Johnson D. E., Cannady S. B., Lehman T. M. and Landreth G. E. (1999) Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins. J. Neurosci. 19, 928-939.
10. Combs C. K., Karlo J. C., Kao S. C. and Landreth G. E. (2001) beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J. Neurosci. 21, 1179-1188.
11. DeMattos R. B., O'Dell M. A., Parsadanian M., Taylor J. W., Harmony J. A., Bales K. R., Paul S. M., Aronow B. J. and Holtzman D. M. (2002) Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease. Proc. Natl Acad. Sci. USA 99, 10 843-10 848.
12. DeMattos R. B., Cirrito J. R., Parsadanian M. et al. (2004) ApoE and cluslerin cooperatively suppress Abeta levels and deposition. Evidence that ApoE regulates extracellular Abeta metabolism in vivo. Neuron 41, 193-202.
13. Ding A. H., Nathan C. F. and Stuehr D. J. (1988) Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141, 2407-2412.
14. Pagan A. M., Holtzman D. M., Munson G. et al. (1999) Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-/-), and human apoE transgenic mice. J. Biol. Chem. 274, 30 001-30 007.
15. Finch C. E., ed. (1999) Clusterin in Normal Brain Functions and During Neurodegeneration. Landes Bioscience Publishers, Austin.
16. Frautschy S. A., Yang F., Calderon L. and Cole G. M. (1996) Rodent models of Alzheimer's disease: rat A beta infusion approaches to amyloid deposits. Neurobiol. Aging 17, 311-321.
17. Frautschy S. A., Horn D. L., Sigel J. J., Harris-White M. E., Mendoza J. J., Yang F., Saido T. C. and Cole G. M. (1998) Protease inhibitor coinfusion with amyloid beta-protein results in enhanced deposition and toxicity in rat brain. J. Neurosci. 18, 8311-8321.
18. Ghiso J., Matsubara E., Koudinov A., Choi-Miura N. H., Tomita M., Wisniewski T. and Frangione B. (1993) The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex. Biochem. J. 293, 27-30.
19. Giulian D. and Baker T. J. (1986) Characterization of ameboid microglia isolated from developing mammalian brain. J. Neurosci. 6, 2163-2178.
20. Han B. H., DeMattos R. B., Dugan L. L. et al. (2001) Clusterin contributes to caspase-3-independent brain injury following neonatal hypoxia-ischemia. Nat. Med. 7, 338-343.
21. Heneka M. T., Wiesinger H., Dumitrescu-Ozimek L., Riederer P., Feinstein D. L. and Klockgether T. (2001) Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide: synthase in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60, 906-916.
22. Holtzman D. M. (2004) In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathology. J. Mol. Neurosci. 23, 247-254.
23. Humphreys D., Hochgrebe T. T., Easterbrook-Smith S. B., Tenniswood M. P. and Wilson M. R. (1997) Effects of clusterin overexpression on TNFalpha- and TGFbeta-mediated death of L929 cells. Biochemistry 36, 15 233-15 243.
24. Innerarity T. L., Pitas R. E. and Mahley R. W. (1986) Lipiprotein-receptor interactions. Methods Enzymol. 129, 542-565.
25. Jones S. E. and Jomary C. (2002) Clusterin. Int. J. Biochem. Cell Biol. 34, 427-431.
26. Karp H. L., Tillotson M. L., Soria J., Reich C. and Wood J. G. (1994) Microglial tyrosine phosphorylation systems in normal and degenerating brain. Glia 11, 284-290.
27. Kida E., Choi-Miura N. H. and Wisniewski K. E. (1995) Deposition of apolipoproteins E and J in senile plaques is topographically determined in both Alzheimer's disease and Down's syndrome brain. Brain Res. 685, 211-216.
28. Klein W. L., Krafft G. A. and Finch C. E. (2001) Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci. 24, 219-224.
29. Korematsu K., Goto S., Nagahiro S. and Ushio Y. (1994) Microglial response to transient focal cerebral ischemia: an immunocytochemical study on the rat cerebral cortex using anti-phosphotyrosine antibody. J. Cereb. Blood Flow Metab. 14, 825-830.
30. Kounnas M. Z., Loukinova E. B., Stefansson S., Harmony J. A., Brewer B. H., Strickland D. K. and Argraves W. S. (1995) Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin. J. Biol. Chem. 270, 13 070-13 075.
31. LaDu M. J., Gilligan S. M., Lukens J. R., Cabana V. G., Reardon C. A., Van Eldik L. J. and Holtzman D. M. (1998) Nascent astrocyte particles differ from lipoproteins in CSF. J. Neurochem. 70, 2070-2081.
32. LaFerla F. M., Troncoso J. C., Strickland D. K., Kawas C. H. and Jay G. (1997) Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization. J. Clin. Invest. 100, 310-320.
33. Lambert M. P., Barlow A. K., Chromy B. A. et al. (1998) Diffusible, nonfibrillar ligands derived from Abetal-42 are potent central nervous system neurotoxins. Proc. Natl Acad. Sci. USA 95, 6448-6453.
34. Lambert M. P., Viola K. L., Chromy B. A., Chang L., Morgan T. E. YuJ., Venton D. L., Krafft G. A., Finch C. E. and Klein W. L. (2001) Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies. J. Neurochem. 79, 595-605.
35. Lassmann H., Zimprich F., Vass K. and Hickey W. F. (1991) Microglial cells are a component of the perivascular glia limitans. J. Neurosci. Res. 28, 236-243.
36. Leskov K. S., Klokov D. Y., Li J., Kinsella T. J. and Boothman D. A. (2003) Synthesis and functional analyses of nuclear clusterin, a cell death protein. J. Biol. Chem. 278, 11 590-11 600.
37. Lidstrom A. M., Bogdanovic N., Hesse C., Volkman I., Davidsson P. and Blennow K. (1998) Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease. Exp. Neurol. 154, 511-521.
38. Matsubara E., Frangione B. and Ghiso J. (1995) Characterization of apolipoprotein J-Alzheimer's A beta interaction. J. Biol. Chem. 270, 7563-7567.
39. May P. C., Lampert-Etchells M., Johnson S. A., Poirier J., Masters J. N. and Finch C. E. (1990) Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat. Neuron 5, 831-839.
40. McDonald D. R., Bamberger M. E., Combs C. K. and Landreth G. E. (1998) beta-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes. J. Neurosci. 18, 4451-4460.
41. McGeer P. L., Kawamata T. and Walker D. G. (1992) Distribution of clusterin in Alzheimer brain tissue. Brain Res. 579, 337-341.
42. Meda L., Cassatella M. A., Szendrei G. I., Otvos L. Jr, Baron P., Villalba M., Ferrari D. and Rossi F. (1995) Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 374, 647-650.
43. Morgan T. E., Laping N. J., Rozovsky I., Oda T., Hogan T. H., Finch C. E. and Pasinetti G. M. (1995) Clusterin expression by astrocytes is influenced by transforming growth factor beta 1 and heterotypic cell interactions. J. Neuroimmunol. 58, 101-110.
44. Oda T., Pasinetti G. M., Osterburg H. H., Anderson C., Johnson S. A. and Finch C. E. (1994) Purification and characterization of brain Clusterin. Biochem. Biophys. Res. Commun. 204, 1131-1136.
45. Oda T., Wals P., Osterburg H. H., Johnson S. A., Pasinetti G. M., Morgan T. E., Rozovsky I., Stine W. B., Snyder S. W. and Holzman T. F. (1995) Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress. Exp. Neurol. 136, 22-31.
46. Pasinetti G. M., Johnson S. A., Oda T., Rozovsky I. and Finch C. E. (1994) Clusterin (SGP-2): a multifunctional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain. J. Comp Neurol. 339, 387-400.
47. Patel N. V., Wie M., Wong A., Finch C. E. and Morgan T. E. (2004) Progressive changes in regulation of apolipoproteins E and J in glial cultures during postnatal development and aging. Neurosci. Lett. 371, 199-204.
48. Ridet J. L., Malhotra S. K., Privat A. and Gage F. H. (1997) Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci. 20, 570-577.
49. Rozovsky I., Morgan T. E., Willoughby D. A., Dugichi-Djordjevich M. M., Pasinetti G. M., Johnson S. A. and Finch C. E. (1994) Selective expression of clusterin (SGP-2) and complement C1qB and C4 during responses to neurotoxins in vivo and in vitro. Neuroscience 62, 741-758.
50. Schwochau G. B., Nath K. A. and Rosenberg M. E. (1998) Clusterin protects against oxidative stress in vitro through aggregative and nonaggregative properties. Kidney Int. 53, 1647-1653.
51. Sensibar J. A., Sutkowski D. M., Raffo A., Buttyan R., Griswold M. D., Sylvester S. R., Kozlowski J. M. and Lee C. (1995) Prevention of cell death induced by tumor necrosis factor alpha in LNCaP cells by overexpression of sulfated glycoprotein-2 (clusterin). Cancer Res. 55, 2431-2437.
52. Senut M. C., Jazat F., Choi N. H. and Lamour Y. (1992) Protein SP40,40-like immunoreactivity in the rat brain: progressive increase with age. Eur. J. Neurosci. 4, 917-928.
53. Smith B. J. (1996) Chemical cleavage of proteins at cysteinyl residues. The Protein Protocols Handbook (Walker J. M., ed), Humana Press, Totowa, NJ, USA.
54. Tarkowski E., Blennow K., Wallin A. and Tarkowski A. (1999) Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia. J. Clin. Immunol. 19, 223-230.
55. Trougakos I. P., So A., Jansen B., Gleave M. E. and Gonos E. S. (2004) Silencing expression of the clusterin/apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress. Cancer Res. 64, 1834-1842.
56. Verbeek M. M., Otte-Holler I., Veerhuis R., Ruiter D. J. and De Waal R. M. (1998) Distribution of A beta-associated proteins in cerebrovascular amyloid of Alzheimer's disease. Acta Neuropathol. (Berl.) 96, 628-636.
57. Viard I., Wehrli P., Jomot L., Bullani R., Vechietti J. L., Schifferli J. A., Tschopp J. and French L. E. (1999) Clusterin gene expression mediates resistance to apoptotic cell death induced by heat shock and oxidative stress. J. Invest. Dermatol. 112, 290-296.
58. Williams K., Alvarez X. and Lackner A. A. (2001) Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system. Glia 36, 156-164.
59. Wood P. L. (1995) Microglia as a unique cellular target in the treatment of stroke: potential neurotoxic mediators produced by activated microglia. Neurol. Res. 17, 242-248.
60. Xie Z., Wei M., Morgan T. E., Fabrizio P., Han D., Finch C. E. and Longo V. D. (2002) Peroxynitrite mediates neurotoxicity of amyloid beta-peptide1-42- and lipopolysaccharide-activated microglia. J. Neurosci. 22, 3484-3492.
61. Yang C. R., Leskov K., Hosley-Eberlein K., Criswell T., Pink J. J., Kinsella T. J. and Boothman D. A. (2000) Nuclear clusterin/XIP8, an x-ray-induced Ku70-binding protein that signals cell death. Proc. Natl Acad. Sci. USA 97, 5907-5912.
62. Zhan S. S., Veerhuis R., Kamphorst W. and Eikelenboom P. (1995) Distribution of beta amyloid associated proteins in plaques in Alzheimer's disease and in the non-demented elderly. Neurodegeneration 4, 291-297.
63. Zlokovic B. V., Martel C. L., Matsubara E., McComb J. G., Zheng G., McCluskey R. T., Frangione B. and Ghiso J. (1996) Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers. Proc. Natl Acad. Sci. USA 93, 4229-4234.